Clinical Trial Update: Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing hypoxia PET tracers FAZA and F-miso in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED